Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematologic malignancies of Cote d'Or (Burgundy, France)
Authors:
Open Access
- 22 October 2010
- journal article
- research article
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 96 (1) , 55-61
Abstract
Background Epidemiological data on myeloid malignancies are very rare in the literature due to a lack of registration by cancer registries until 2000. The Registry of Hematologic Malignancies of the Côte d’Or Department in France has, however, steadfastly registered data on cases occurring in the Department since 1980, resulting, to date, in a database of over 5,000 cases classified according to the ICD-O-3 classification, following the most recent World Health Organization classification criteria. Design and Methods Twenty-five years of data on myeloid malignancies, including acute myeloid leukemia, myeloproliferative neoplasms, myelodysplastic syndromes and myelodysplastic/myeloproliferative syndromes were analyzed. World population standardized incidence rates were calculated as were as observed and relative survival. Results Incidence rates per 100,000 inhabitants/year were 2.5 for acute myeloid leukemia, 1.3 for myelodysplastic syndromes, 3.2 for myeloproliferative neoplasms and 0.6 for myelodysplastic/myeloproliferative syndromes. It was found that the incidence rate of myelodysplastic syndromes increased significantly over the period. The median overall survival is 8.9 months for patients with acute myeloid leukemia, 33.8 months for patients with myelodysplastic syndromes, 91.7 months for those with myeloproliferative neoplasms and 26.6 months for patients with myelodysplastic/myeloproliferative syndromes. Observed and relative 20-year survival rates are, respectively, 12% and 13% in acute myeloid leukemia, 2% and 6% in myelodysplastic syndromes and 20% and 34% in myeloproliferative neoplasms. Conclusions These population-based data on myeloid malignancies are the first data collected over such a long period and provide interesting information for clinicians and public health authorities, particularly given the paucity of other long-term, population-based data from cancer registries.Keywords
This publication has 24 references indexed in Scilit:
- Significant increase in the apparent incidence of essential thrombocythemia related to new WHO diagnostic criteria: a population-based studyHaematologica, 2009
- No increase in age-specific incidence of myelodysplastic syndromes.2004
- Trends in the incidence of chronic Philadelphia chromosome negative (Ph‐) myeloproliferative disorders in the city of Göteborg, Sweden, during 1983–99Journal of Internal Medicine, 2004
- Cytogenetic findings in adult de novo acute myeloid leukaemia. A population‐based study of 303/337 patientsBritish Journal of Haematology, 2003
- Trends in leukemia incidence and survival in the United States (1973–1998)Cancer, 2003
- Cancer incidence in five continents. Volume VIII.2002
- Increase therapy-related leukemia secondary to breast cancerLeukemia, 2000
- Epidemiological characteristics of myelodysplastic syndrome in a well-defined French populationBritish Journal of Cancer, 1996
- Myelodysplastic Syndrome: Prospective Evaluation of Fifty-One Patients Using the Dutcher Scoring SystemActa Haematologica, 1989
- Haematopoietic malignancies in Côte d'Or (France): A population based studyBritish Journal of Cancer, 1986